Sommario

• • ·Table of Contents

    Pagina :A1

    
• • ·Editorial Board

    Pagina :A7

    
• • ·Information for Readers

    Pagina :A8

    

• Editorials

  • ·A call to standardize symptom presentation in acute coronary syndromes

    Pagina :801-806

    John G. Canto, Robert J. Goldberg, George Sopko

    Mappa Mappa  
  • ·Invited editorial commentary for American Heart Journal mechanisms of exercise training in heart failure with preserved ejection fraction: Central disappointment and peripheral promise

    Pagina :807-809

    Dalane W. Kitzman, Mark J. Haykowsky

    

• Trial Design

  • ·Optimized Duration of Clopidogrel Therapy Following Treatment with the Endeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice (OPTIMIZE) Trial: Rationale and design of a large-scale, randomized, multicenter study

    Pagina :810

    Fausto Feres, Ricardo A. Costa, Deepak L. Bhatt, Martin B. Leon, Roberto V. Botelho, Spencer B. King, J. Eduardo T. de Paula, José A. Mangione, Décio Salvadori, Marcos O. Gusmão, Hélio Castello, Eduardo Nicolela, Marco A. Perin, Fernando S. Devito, J. Antônio Marin-Neto, Alexandre Abizaid

    Riassunto Riassunto Mappa Mappa  
  • ·Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy

    Pagina :817

    Philippe Gabriel Steg, Shamir R. Mehta, Charles V. Pollack, Christoph Bode, Christophe Gaudin, Karen Fanouillere, Angele Moryusef, Stephen D. Wiviott, Marc S. Sabatine

    Riassunto Riassunto Mappa Mappa  
  • ·Risk stratification in acute heart failure: Rationale and design of the STRATIFY and DECIDE studies

    Pagina :825-834

    Sean P. Collins, Christopher J. Lindsell, Cathy A. Jenkins, Frank E. Harrell, Gregory J. Fermann, Karen F. Miller, Sue N. Roll, Matthew I. Sperling, David J. Maron, Allen J. Naftilan, John A. McPherson, Neal L. Weintraub, Douglas B. Sawyer, Alan B. Storrow

    Riassunto Riassunto Mappa Mappa  

• Curriculum in Cardiology

  • ·A qualitative systematic review of influences on attendance at cardiac rehabilitation programs after referral

    Pagina :835

    Alexander M. Clark, Kathryn M. King-Shier, David R. Thompson, Melisa A. Spaling, Amanda S. Duncan, James A. Stone, Susan B. Jaglal, Jan E. Angus

    Riassunto Riassunto Mappa Mappa  

• Cardiac Safety Research Consortium

  • ·Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction

    Pagina :846-855

    Jennifer B. Christian, John K. Finkle, Bonnie Ky, Pamela S. Douglas, David E. Gutstein, Paul D. Hockings, Pierre Lainee, Daniel J. Lenihan, Jay W. Mason, Philip T. Sager, Thomas G. Todaro, Karen A. Hicks, Robert C. Kane, Hon-Sum Ko, JoAnn Lindenfeld, Eric L. Michelson, James Milligan, Jiefen Y. Munley, Joel S. Raichlen, Amir Shahlaee, Colette Strnadova, Brenda Ye, J. Rick Turner

    Riassunto Riassunto Mappa Mappa

• Clinical Investigations

  • ·Presenting symptoms of myocardial infarction predict short- and long-term mortality: The MONICA/KORA Myocardial Infarction Registry

    Pagina :856-861

    Inge Kirchberger, Margit Heier, Bernhard Kuch, Wolfgang von Scheidt, Christa Meisinger

    Riassunto Riassunto Mappa Mappa  
  • ·Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: An analysis from Diuretic Optimization Strategies in Acute Heart Failure

    Pagina :862-868

    Ravi V. Shah, Steven McNulty, Christopher M. O'Connor, G. Michael Felker, Eugene Braunwald, Michael M. Givertz

    Riassunto Riassunto Mappa Mappa  
  • ·Cardiovascular effects of 1 year of progressive endurance exercise training in patients with heart failure with preserved ejection fraction

    Pagina :869-877

    Naoki Fujimoto, Anand Prasad, Jeffrey L. Hastings, Paul S. Bhella, Shigeki Shibata, Dean Palmer, Benjamin D. Levine

    Riassunto Riassunto Mappa Mappa  
  • ·The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

    Pagina :878-883

    Lars Gullestad, Thor Ueland, John Kjekshus, Ståle H. Nymo, Johannes Hulthe, Pieter Muntendam, John J.V. McMurray, John Wikstrand, Pål Aukrust

    Riassunto Riassunto Mappa Mappa  
  • ·Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: Findings from the EVEREST Trial

    Pagina :884

    Robert J. Mentz, Matthew J. Chung, Mihai Gheorghiade, Peter S. Pang, Mary J. Kwasny, Andrew P. Ambrosy, Muthiah Vaduganathan, Christopher M. O'Connor, Karl Swedberg, Faiez Zannad, Marvin A. Konstam, Aldo P. Maggioni

    Riassunto Riassunto Mappa Mappa  
  • ·Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: A double-blind randomized controlled feasibility study

    Pagina :893-901

    Martin Stout, Garry A. Tew, Helen Doll, Irena Zwierska, Nicola Woodroofe, Kevin S. Channer, John M. Saxton

    Riassunto Riassunto Mappa Mappa  
  • ·Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease

    Pagina :902

    Hector Tamez, Carmine Zoccali, David Packham, Julia Wenger, Ishir Bhan, Evan Appelbaum, Yili Pritchett, Yuchiao Chang, Rajiv Agarwal, Christoph Wanner, Donald Lloyd-Jones, Jorge Cannata, B. Taylor Thompson, Dennis Andress, Wuyan Zhang, Bhupinder Singh, Daniel Zehnder, Ajay Pachika, Warren J. Manning, Amil Shah, Scott D. Solomon, Ravi Thadhani

    Riassunto Riassunto Mappa Mappa  
  • ·Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: A propensity score–matched case-control study

    Pagina :910-917

    Azeem Latib, Francesco Maisano, Letizia Bertoldi, Andrea Giacomini, Joanne Shannon, Micaela Cioni, Alfonso Ielasi, Filippo Figini, Kensuke Tagaki, Annalisa Franco, Remo Daniel Covello, Antonio Grimaldi, Pietro Spagnolo, Gill Louise Buchannan, Mauro Carlino, Alaide Chieffo, Matteo Montorfano, Ottavio Alfieri, Antonio Colombo

    Riassunto Riassunto Mappa Mappa  
  • ·Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery

    Pagina :918-924

    Prashant D. Bhave, L. Elizabeth Goldman, Eric Vittinghoff, Judith Maselli, Andrew Auerbach

    Riassunto Riassunto Mappa Mappa
  • ·Cardiovascular risk assessment: Addition of CKD and race to the Framingham equation

    Pagina :925

    Paul E. Drawz, Sarah Baraniuk, Barry R. Davis, Clinton D. Brown, Pedro J. Colon, Aloysius B. Cujyet, Richard A. Dart, James F. Graumlich, Mario A. Henriquez, Jamaluddin Moloo, Mohammed G. Sakalayen, Debra L. Simmons, Carol Stanford, Mary Ellen Sweeney, Nathan D. Wong, Mahboob Rahman

    Riassunto Riassunto Mappa Mappa  

• Letters to the Editor

  • ·Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

    Pagina :e19

    Gen-Min Lin, Yi-Hwei Li, Lamin E.S. Jaiteh, Chih-Lu Han

    
  • ·Blocking the terminal complement complex: Mismatch and misconception

    Pagina :e21

    Pierre Theroux, Catherine Martel, Arnaud Bonnefoy

    
  • ·Letter to the Editor concerning article “Design of the Trial to Assess Chelation Therapy (TACT)”

    Pagina :e23

    Edzard Ernst

    
  • ·Reply to letter to the editor by Edzard Ernst

    Pagina :e25

    Gervasio A. Lamas